Back
Aquestive Therapeutics Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
63
AQST
Aquestive Therapeutics
Last Price:
5.20
Seasonality Move:
11.7%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AQST is experiencing slight buying pressure.
Aquestive Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.79 | Buy |
| 20-day SMA: | 4.56 | Buy |
| 50-day SMA: | 3.89 | Buy |
| 200-day SMA: | 3.32 | Buy |
| 8-day EMA: | 4.76 | Buy |
| 20-day EMA: | 4.52 | Buy |
| 50-day EMA: | 4.05 | Buy |
| 200-day EMA: | 3.28 | Buy |
Aquestive Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 61.82 | Buy |
| Chaikin Money Flow: | 96799 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.2 - 4.76) | Buy |
| Bollinger Bands (100): | (2.69 - 4.15) | Buy |
Aquestive Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aquestive Therapeutics Stock
Is Aquestive Therapeutics Stock a Buy?
- Aquestive Therapeutics share price is 4.95 while AQST 8-day simple moving average is 4.79, which is a Buy signal.
- The stock price of AQST is 4.95 while Aquestive Therapeutics 20-day SMA is 4.56, which makes it a Buy.
- Aquestive Therapeutics 50-day simple moving average is 3.89 while AQST share price is 4.95, making it a Buy technically.
- AQST stock price is 4.95 and Aquestive Therapeutics 200-day simple moving average is 3.32, creating a Buy signal.
AQST Technical Analysis vs Fundamental Analysis
Buy
63
Aquestive Therapeutics (AQST)
is a Buy
Is Aquestive Therapeutics a Buy or a Sell?
-
Aquestive Therapeutics stock is rated a Buy
The current Aquestive Therapeutics [AQST] share price is $4.95. The Score for AQST is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Aquestive Therapeutics Stock Info
Market Cap:
450.75M
Price in USD:
4.95
Share Volume:
1.13M
Aquestive Therapeutics 52-Week Range
52-Week High:
6.23
52-Week Low:
1.25
Buy
63
Aquestive Therapeutics (AQST)
is a Buy
Aquestive Therapeutics Share Price Forecast
-
What is the Aquestive Therapeutics stock price today?
The Aquestive Therapeutics stock price is 4.95 USD today. -
Will AQST stock go up or go down?
Aquestive Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aquestive Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aquestive Therapeutics is not overvalued.
Is Aquestive Therapeutics Stock a Buy?
- Aquestive Therapeutics share price is 4.95 while AQST 8-day exponential moving average is 4.76, which is a Buy signal.
- The stock price of AQST is 4.95 while Aquestive Therapeutics 20-day EMA is 4.52, which makes it a Buy.
- Aquestive Therapeutics 50-day exponential moving average is 4.05 while AQST share price is 4.95, making it a Buy technically.
- AQST stock price is 4.95 and Aquestive Therapeutics 200-day simple moving average is 3.28, creating a Buy signal.
Fundamental Analysis of Aquestive Therapeutics
Is Aquestive Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Aquestive Therapeutics
Should I short Aquestive Therapeutics stock?
- AQST Moving Average Covergence Divergence (MACD) indicator is 0.27, suggesting Aquestive Therapeutics is a Buy
- Aquestive Therapeutics Relative Strength Index (RSI) is 61.82, which suggest Aquestive Therapeutics is overbought
- The Bollinger Bands (25) for Aquestive Therapeutics is (4.2 - 4.76), which suggest Aquestive Therapeutics is a Buy
- The Bollinger Bands (100) for Aquestive Therapeutics is (2.69 - 4.15), which suggest Aquestive Therapeutics is a Buy
* Aquestive Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.